Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pulmonary Hypertension

  Free Subscription


Articles published in J Perinatol

Retrieve available abstracts of 57 articles:
HTML format



Single Articles


    March 2021
  1. DASGUPTA S, Richardson JC, Aly AM, Jain SK, et al
    Role of functional echocardiographic parameters in the diagnosis of bronchopulmonary dysplasia-associated pulmonary hypertension.
    J Perinatol. 2021 Mar 8. pii: 10.1038/s41372-021-01009.
    PubMed     Abstract available


  2. SEABROOK RB, Grover TR, Rintoul N, Weems M, et al
    Treatment of pulmonary hypertension during initial hospitalization in a multicenter cohort of infants with congenital diaphragmatic hernia (CDH).
    J Perinatol. 2021 Mar 1. pii: 10.1038/s41372-021-00923.
    PubMed     Abstract available


    February 2021
  3. ALEEM S, Robbins C, Murphy B, Elliott S, et al
    The use of supplemental hydrocortisone in the management of persistent pulmonary hypertension of the newborn.
    J Perinatol. 2021 Feb 15. pii: 10.1038/s41372-021-00943.
    PubMed     Abstract available


  4. MAT BAH MN, Tan RYH, Razak H, Sapian MH, et al
    Survival and associated risk factors for mortality among infants with persistent pulmonary hypertension of the newborn in Malaysia.
    J Perinatol. 2021 Feb 15. pii: 10.1038/s41372-021-00962.
    PubMed     Abstract available


  5. KESTING AC, Hansmann G, Sallmon H
    Toward a standardized multidisciplinary team approach in preterm infants at-risk for pulmonary hypertension.
    J Perinatol. 2021 Feb 9. pii: 10.1038/s41372-021-00949.
    PubMed    


    January 2021
  6. AGARWAL P, Shankaran S, Laptook AR, Chowdhury D, et al
    Outcomes of infants with hypoxic ischemic encephalopathy and persistent pulmonary hypertension of the newborn: results from three NICHD studies.
    J Perinatol. 2021 Jan 6. pii: 10.1038/s41372-020-00905.
    PubMed     Abstract available


    September 2020
  7. GONZALEZ A, Bancalari A, Osorio W, Luco M, et al
    Correction: Early use of combined exogenous surfactant and inhaled nitric oxide reduces treatment failure in persistent pulmonary hypertension of the newborn: a randomized controlled trial.
    J Perinatol. 2020 Sep 7. pii: 10.1038/s41372-020-00806.
    PubMed     Abstract available


    August 2020
  8. SAHNI M, Yeboah B, Das P, Shah D, et al
    Novel biomarkers of bronchopulmonary dysplasia and bronchopulmonary dysplasia-associated pulmonary hypertension.
    J Perinatol. 2020 Aug 18. pii: 10.1038/s41372-020-00788.
    PubMed     Abstract available


  9. HEBERT A, Drolet C, Altit G, Villeneuve A, et al
    Management of chronic pulmonary hypertension in neonates with bronchopulmonary dysplasia: perspectives of neonatologists with hemodynamic expertise and pediatric cardiologists.
    J Perinatol. 2020 Aug 16. pii: 10.1038/s41372-020-00791.
    PubMed    


  10. GONZALEZ A, Bancalari A, Osorio W, Luco M, et al
    Early use of combined exogenous surfactant and inhaled nitric oxide reduces treatment failure in persistent pulmonary hypertension of the newborn: a randomized controlled trial.
    J Perinatol. 2020 Aug 13. pii: 10.1038/s41372-020-00777.
    PubMed     Abstract available


    July 2020
  11. BISCHOFF AR, Giesinger RE, Bell EF, McNamara PJ, et al
    Precision medicine in neonatal hemodynamics: need for prioritization of mechanism of illness and defining population of interest.
    J Perinatol. 2020 Jul 27. pii: 10.1038/s41372-020-0741.
    PubMed    


    June 2020
  12. GRIFFITHS M, Yang J, Everett AD, Jennings JM, et al
    Correction: Endostatin and ST2 are predictors of pulmonary hypertension disease course in infants.
    J Perinatol. 2020 Jun 2. pii: 10.1038/s41372-020-0700.
    PubMed     Abstract available


    May 2020
  13. KEUSTERS L, Purna J, Deshpande P, Mertens L, et al
    Clinical validity of systemic arterial steal among extremely preterm infants with persistent patent ductus arteriosus.
    J Perinatol. 2020 May 11. pii: 10.1038/s41372-020-0663.
    PubMed     Abstract available


  14. GRIFFITHS M, Yang J, Everett AD, Jennings JM, et al
    Endostatin and ST2 are predictors of pulmonary hypertension disease course in infants.
    J Perinatol. 2020 May 4. pii: 10.1038/s41372-020-0671.
    PubMed     Abstract available


    April 2020
  15. OSMAN A
    Contributions of Ibn Alnafis to the correct understanding of the circulation.
    J Perinatol. 2020;40:688.
    PubMed    


  16. XIONG T, Kulkarni M, Gokulakrishnan G, Shivanna B, et al
    Natriuretic peptides in bronchopulmonary dysplasia: a systematic review.
    J Perinatol. 2020;40:607-615.
    PubMed     Abstract available


    January 2020
  17. NAEEM B, Ayub A, Aly AM, Malloy MH, et al
    Urinary NT-proBNP as a potential noninvasive biomarker for screening of pulmonary hypertension in preterm infants: a pilot study.
    J Perinatol. 2020 Jan 7. pii: 10.1038/s41372-019-0581.
    PubMed     Abstract available


    November 2019
  18. SHETH S, Goto L, Bhandari V, Abraham B, et al
    Factors associated with development of early and late pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.
    J Perinatol. 2019 Nov 13. pii: 10.1038/s41372-019-0549.
    PubMed     Abstract available


  19. SHARMA J, Sherman A, Rimal A, Haney B, et al
    Neonatal respiratory extracorporeal membrane oxygenation and primary diagnosis: trends between two decades.
    J Perinatol. 2019 Nov 7. pii: 10.1038/s41372-019-0547.
    PubMed     Abstract available


    August 2019
  20. AGGARWAL S, Agarwal P, Natarajan G
    Echocardiographic prediction of severe pulmonary hypertension in neonates undergoing therapeutic hypothermia for hypoxic-ischemic encephalopathy.
    J Perinatol. 2019 Aug 30. pii: 10.1038/s41372-019-0442.
    PubMed     Abstract available


    July 2019
  21. SINGH A, Feingold B, Rivera-Lebron B, Weiner D, et al
    Correlating objective echocardiographic parameters in patients with pulmonary hypertension due to bronchopulmonary dysplasia.
    J Perinatol. 2019 Jul 16. pii: 10.1038/s41372-019-0429.
    PubMed     Abstract available


    March 2019
  22. BREATNACH CR, Bussmann N, Smith A, Levy P, et al
    Cardiac mechanics in infants with Down syndrome in the early neonatal period.
    J Perinatol. 2019 Mar 25. pii: 10.1038/s41372-019-0354.
    PubMed     Abstract available


  23. AGARWAL P, Altinok D, Desai J, Shanti C, et al
    In-hospital outcomes of neonates with hypoxic-ischemic encephalopathy receiving extracorporeal membrane oxygenation.
    J Perinatol. 2019 Mar 6. pii: 10.1038/s41372-019-0345.
    PubMed     Abstract available


  24. GAFFAR S, Ellini AR, Ahmad I, Chen Y, et al
    Left ventricular cardiac output is a reliable predictor of extracorporeal life support in neonates with congenital diaphragmatic hernia.
    J Perinatol. 2019 Mar 5. pii: 10.1038/s41372-019-0348.
    PubMed     Abstract available


    January 2019
  25. ALTIT G, Bhombal S, Hopper RK, Tacy TA, et al
    Death or resolution: the "natural history" of pulmonary hypertension in bronchopulmonary dysplasia.
    J Perinatol. 2019 Jan 7. pii: 10.1038/s41372-018-0303.
    PubMed     Abstract available


    November 2018
  26. MCCRARY AW, Barker PCA, Torok RD, Spears TG, et al
    Agreement of an echocardiogram-based diagnosis of pulmonary hypertension in infants at risk for bronchopulmonary dysplasia among masked reviewers.
    J Perinatol. 2018 Nov 21. pii: 10.1038/s41372-018-0277.
    PubMed     Abstract available


    October 2018
  27. MANJA V, Guyatt G, Lakshminrusimha S, Jack S, et al
    Factors influencing decision making in neonatology: inhaled nitric oxide in preterm infants.
    J Perinatol. 2018 Oct 23. pii: 10.1038/s41372-018-0258.
    PubMed     Abstract available


  28. NEARY E, Jain A
    Right ventricular congestion in preterm neonates with chronic pulmonary hypertension.
    J Perinatol. 2018 Oct 8. pii: 10.1038/s41372-018-0241.
    PubMed    


  29. COLLURA CA, Mara KC, Weaver AL, Clark RH, et al
    Outcomes of early inhaled nitric oxide use in premature African American neonates.
    J Perinatol. 2018 Oct 1. pii: 10.1038/s41372-018-0232.
    PubMed     Abstract available


    August 2018
  30. SURESH G, King B, Jain SK
    Response to Letter to Editor re: "Screening for pulmonary hypertension in preterm infants-not ready for prime time".
    J Perinatol. 2018 Aug 10. pii: 10.1038/s41372-018-0194.
    PubMed    


    July 2018
  31. AHMAD KA, Banales J, Henderson CL, Ramos SE, et al
    Intravenous epoprostenol improves oxygenation index in patients with persistent pulmonary hypertension of the newborn refractory to nitric oxide.
    J Perinatol. 2018 Jul 25. pii: 10.1038/s41372-018-0179.
    PubMed     Abstract available


  32. DASGUPTA S, Aly AM, Malloy MH, Okorodudu AO, et al
    NTproBNP as a surrogate biomarker for early screening of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.
    J Perinatol. 2018 Jul 6. pii: 10.1038/s41372-018-0164.
    PubMed     Abstract available


    May 2018
  33. MCANDREW S, Acharya K, Nghiem-Rao TH, Leuthner S, et al
    NICU management and outcomes of infants with trisomy 21 without major anomalies.
    J Perinatol. 2018 May 25. pii: 10.1038/s41372-018-0136.
    PubMed     Abstract available


  34. PAPADHIMA I, Louis D, Purna J, Deshpande P, et al
    Targeted neonatal echocardiography (TNE) consult service in a large tertiary perinatal center in Canada.
    J Perinatol. 2018 May 22. pii: 10.1038/s41372-018-0130.
    PubMed     Abstract available


    March 2018
  35. AL-LAWAMA M
    Letter to the editor: Treatment of patent ductus arteriosus in premature infants.
    J Perinatol. 2018 Mar 7. pii: 10.1038/s41372-018-0085.
    PubMed    


    December 2017
  36. ALTIT G, Lee HC, Hintz S, Tacy TA, et al
    Practices surrounding pulmonary hypertension and bronchopulmonary dysplasia amongst neonatologists caring for premature infants.
    J Perinatol. 2017 Dec 12. pii: 10.1038/s41372-017-0025.
    PubMed     Abstract available


    November 2017
  37. SURESH G, King BC, Jain SK
    Screening for pulmonary hypertension in preterm infants-not ready for prime time.
    J Perinatol. 2017 Nov 27. pii: 10.1038/s41372-017-0014.
    PubMed    


    October 2017
  38. KANAAN U, Srivatsa B, Huckaby J, Kelleman M, et al
    Association of unit-wide oxygen saturation target on incidence of pulmonary hypertension in very low birthweight premature infants.
    J Perinatol. 2017 Oct 19. doi: 10.1038/jp.2017.
    PubMed     Abstract available


    September 2017
  39. KUNJUNJU AM, Gopagondanahalli KR, Chan Y, Sehgal A, et al
    Bronchopulmonary dysplasia-associated pulmonary hypertension: clues from placental pathology.
    J Perinatol. 2017 Sep 7. doi: 10.1038/jp.2017.
    PubMed     Abstract available


    June 2017
  40. BENTSEN MH, Satrell E, Reigstad H, Johnsen SL, et al
    Mid-childhood outcomes after pre-viable preterm premature rupture of membranes.
    J Perinatol. 2017 Jun 29. doi: 10.1038/jp.2017.
    PubMed     Abstract available


  41. DEVRIES LB, Heyne RJ, Ramaciotti C, Brown LS, et al
    Mortality among infants with evolving bronchopulmonary dysplasia increases with major surgery and with pulmonary hypertension.
    J Perinatol. 2017 Jun 15. doi: 10.1038/jp.2017.
    PubMed     Abstract available


    April 2017
  42. JACKSON W, Hornik CP, Messina JA, Guglielmo K, et al
    In-hospital outcomes of premature infants with severe bronchopulmonary dysplasia.
    J Perinatol. 2017 Apr 6. doi: 10.1038/jp.2017.
    PubMed     Abstract available


    February 2017
  43. WEISMANN CG, Asnes JD, Bazzy-Asaad A, Tolomeo C, et al
    Pulmonary hypertension in preterm infants: results of a prospective screening program.
    J Perinatol. 2017 Feb 16. doi: 10.1038/jp.2016.
    PubMed     Abstract available


    January 2017
  44. ELSAYED YN, Amer R, Seshia MM
    The impact of integrated evaluation of hemodynamics using targeted neonatal echocardiography with indices of tissue oxygenation: a new approach.
    J Perinatol. 2017 Jan 19. doi: 10.1038/jp.2016.
    PubMed     Abstract available


  45. AL-GHANEM G, Shah P, Thomas S, Banfield L, et al
    Bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis.
    J Perinatol. 2017 Jan 12. doi: 10.1038/jp.2016.
    PubMed     Abstract available


    October 2016
  46. HAQUE U, Stiver C, Rivera BK, Richards B, et al
    Right ventricular performance using myocardial deformation imaging in infants with bronchopulmonary dysplasia.
    J Perinatol. 2016 Oct 6. doi: 10.1038/jp.2016.
    PubMed     Abstract available


    July 2016
  47. NAKANISHI H, Uchiyama A, Kusuda S
    Impact of pulmonary hypertension on neurodevelopmental outcome in preterm infants with bronchopulmonary dysplasia: a cohort study.
    J Perinatol. 2016 Jul 21. doi: 10.1038/jp.2016.
    PubMed     Abstract available


    June 2016
  48. ASCHNER JL, Gien J, Ambalavanan N, Kinsella JP, et al
    Challenges, priorities and novel therapies for hypoxemic respiratory failure and pulmonary hypertension in the neonate.
    J Perinatol. 2016;36 Suppl 2:S32-6.
    PubMed     Abstract available


  49. LAKSHMINRUSIMHA S, Saugstad OD
    The fetal circulation, pathophysiology of hypoxemic respiratory failure and pulmonary hypertension in neonates, and the role of oxygen therapy.
    J Perinatol. 2016;36 Suppl 2:S3-S11.
    PubMed     Abstract available


  50. GIEN J, Kinsella JP
    Management of pulmonary hypertension in infants with congenital diaphragmatic hernia.
    J Perinatol. 2016;36 Suppl 2:S28-31.
    PubMed     Abstract available


  51. AMBALAVANAN N, Aschner JL
    Management of hypoxemic respiratory failure and pulmonary hypertension in preterm infants.
    J Perinatol. 2016;36 Suppl 2:S20-7.
    PubMed     Abstract available


  52. LAKSHMINRUSIMHA S, Konduri GG, Steinhorn RH
    Considerations in the management of hypoxemic respiratory failure and persistent pulmonary hypertension in term and late preterm neonates.
    J Perinatol. 2016;36 Suppl 2:S12-9.
    PubMed     Abstract available


    May 2016
  53. THAKKAR N, Gonzalez D, Cohen-Wolkowiez M, Massaro MM, et al
    An opportunistic study evaluating pharmacokinetics of sildenafil for the treatment of pulmonary hypertension in infants.
    J Perinatol. 2016 May 12. doi: 10.1038/jp.2016.
    PubMed     Abstract available


    February 2016
  54. KONIG K
    More safety data: what about efficacy of sildenafil?
    J Perinatol. 2016;36:79.
    PubMed    


  55. SAMIEE-ZAFARGHANDY S, van den Anker JN, Laughon MM, Clark RH, et al
    Sildenafil and retinopathy of prematurity risk in very low birth weight infants.
    J Perinatol. 2016;36:137-40.
    PubMed     Abstract available


    June 2015
  56. BALASUBRAMANIAN H, Strunk T, Kohan R
    Arterial hypotension and prerenal failure in an extremely preterm infant associated with oral sildenafil.
    J Perinatol. 2015;35:458-9.
    PubMed     Abstract available


    February 2015
  57. GEDDES GC, Dimmock DP, Hehir DA, Helbling DC, et al
    A novel FOXF1 mutation associated with alveolar capillary dysplasia and coexisting colobomas and hemihyperplasia.
    J Perinatol. 2015;35:155-7.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: